Triage of Elderly Needing Treatment

Recruiting

Conditions: Veroudering, invasieve therapie en de uitkomsten
Ageing
geriatric screening

Registration Number: NL-OMON54793

Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Not specified

Target Recruitment: 2180

Inclusion Criteria

1. Aged 70 years or older at day of presentation or younger than 70 with
indication for frailty
2. Indication intention to treat for:
- Malign process in which a treatment (operation, chemotherapy or radiotherapy)
is considered
- Vascular disease in which a treatment (operation) is considered
- Benign processes in which a treatment (operation, chemotherapy or
radiotherapy) is considered
- Referral to the outpatient department of gerontology and geriatrics for
(neuropsychological) screening or any other reason, subjects older than 70
years could also be included when they are considered vulnerable

Exclusion Criteria

1. Participant not willing to provide informed consent
2. Participant not able to provide informed consent and no proxy available

Study & Design

Study Type: Observational invasive

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Main study end points are:<br /><br><br /><br>The following data will be collected from the medical record after the<br /><br>treatment of the patient is finished:<br /><br>i) duration of admittance<br /><br>ii) days on intensive care or medium care<br /><br>iii) clinical diagnosis of delirium during hospitalization<br /><br>iv) complications during admittance (infections, falls)<br /><br>v) unplanned hospital admittance<br /><br><br /><br>After a Follow-up of 6 and 12 months after procedure we will collect the<br /><br>following data by a telephone call:<br /><br>i) Mortality will be followed through the registry of the municipality (in<br /><br>Dutch: Gemeentelijke Basis Administratie).<br /><br>ii) Functional decline by Katz-ADL<br /><br>iii) Quality of life will be assessed using EuroQOL-5D.<br /><br>iv) Living arrangement (independent, institutionalized, hospitalized) and level<br /><br>of support (number of days home-care)</p><br>

Secondary Outcome Measures